HOME >> BIOLOGY >> NEWS
Sunlight converts common anti-bacterial agent to dioxin

S. Geological Survey published a widely circulated study of chemicals in surface water, in which triclosan was found in 58 percent of natural waters tested. Its median concentration was 0.14 parts per billion; the maximum was 2.3 ppb. McNeill and Arnold chose to study triclosan because they could tell from its structure that it would likely break down in sunlight.

In their study, McNeill and Arnold added triclosan to river water, shined ultraviolet light on the water, and found that between one percent and 12 percent of the triclosan was converted to dioxin.

"The fact that this conversion can happen in surface layers of rivers may not cause harm by itself, but it suggests that more serious reactions--leading to more toxic forms of dioxin--may also happen when triclosan enters the environment," said Arnold. "We want to determine if this is the case." As a first step in sorting out the relations, if any, between triclosan and more toxic dioxin, McNeill and Arnold plan studies to determine whether they tend to occur together in natural waters.

The researchers said that even low levels of very toxic dioxin are worrisome because dioxin readily accumulates in organisms and becomes more concentrated in tissues as it moves up the food chain.

The study was funded by the U.S. Geological Survey, through the National Institutes of Water Resources. Triclosan is manufactured by Ciba-Geigy.


'"/>

Contact: Deane Morrison
morri029@umn.edu
612-624-2346
University of Minnesota
14-Apr-2003


Page: 1 2

Related biology news :

1. Sunlight, PCB exposure enhance skin cancer chances
2. How Nature Harvests Sunlight
3. Researchers discover new oceanic bacterial photopigment that converts light into biochemical energy
4. New process converts municipal waste into commodities and fuel
5. Most recent common ancestor of all living humans surprisingly recent
6. Hidden diversity: DNA barcoding reveals a common butterfly is actually 10 different species
7. European common frog found to use novel mating strategy
8. Genetic clues found for common congenital brain disorder
9. Stanford researchers findings may shed light on common, deadly birth defect
10. U-M scientists find common virus in human prostate tissue
11. Scientists suggest framework for epigenetics in common disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... Research and Markets has announced the addition of the ... offering. ... report provides separate comprehensive analytics for the US, Japan ... Annual estimates and forecasts are provided for the period 2015 through ... Market data and analytics are derived from primary and secondary research. ...
(Date:2/17/2017)... 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) ... oral peptide drug candidates, PTG-100 and PTG-200, at ... Crohn,s and Colitis Organization (ECCO).  The ECCO congress ... from February 15 – 18, 2017. ... on Protagonist drug candidates PTG-100 and PTG-200. PTG-100, ...
(Date:2/16/2017)... BEACH, Fla. , Feb. 16, 2017 /PRNewswire/ ... company revolutionizing the development of liquid biopsy tests ... has entered into an exclusive license agreement with ... distribute MDNA,s proprietary liquid biopsy test for prostate ... South Korea . This is the ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
Breaking Biology Technology:
Cached News: